, resulting in the increase of selling expenses comparing to 1H18 in which we did not have these expenditure. In addition, there are also expenses of sales promotion, booth exhibition, cost of samples, and
, higher repair and maintenance expenditure of medical equipment, and higher depreciation and amortization expenses resulted from the expansions of a new hospital and new specialized centers in the existing
liability 4,470 Registered and paid up capital 1,655 Shareholders’ equity 6,047 Total revenue 3,853 Expenditure 3,075 Net profit (loss) 683 Earning per share (baht) 3.94 Book value per share (baht) 36.54
second portion of the loan of USD 30,000,000, or equivalent to THB 1,035,276,666.67, (the “2nd Loan Portion”) as capital expenditure, as working capital, and for other debt repayments of the Company as
loan of USD 30,000,000, or equivalent to THB 1,035,276,666.67, (the “2nd Loan Portion”) as capital expenditure, as working capital, and for other debt repayments of the Company as approved by Link
YoY. Transfer ownership of condominium unit of the ESSE at Singha Complex, the ESSE Asoke and Banyan Tree Residences Riverside Bangkok mainly attributed to the surge. Residential projects for sales as
% YoY. Transfer ownership of condominium unit of the ESSE at Singha Complex since September 2019, the ESSE Asoke and Banyan Tree Residences Riverside Bangkok mainly attributed to the surge. Residential
, inventories and property, plant and equipment. Cash received from the initial public offering (IPO) and cash from operations contributed to the surge in total assets. Total Liabilities As of 30 June 2018, the
shareholders’ equity of THB 4,973.36 million. The surge in shareholders’ equity was mainly caused by the Company’s initial public offering (IPO) as well as the retained earnings from the Company’s performance
THB 1,264m, grew by THB 948m or 300% YoY. Transfer ownership of condominium unit of the Esse Asoke and Banyan Tree Residences Riverside Bangkok mainly attributed to the surge. Page 3 of 7 Management